Cancel anytime
Relx PLC ADR (RELX)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/24/2024: RELX (2-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 22.33% | Upturn Advisory Performance 3 | Avg. Invested days: 68 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 12/24/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 22.33% | Avg. Invested days: 68 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 12/24/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 85.17B USD |
Price to earnings Ratio 36.71 | 1Y Target Price 50.12 |
Dividends yield (FY) 1.68% | Basic EPS (TTM) 1.25 |
Volume (30-day avg) 752363 | Beta 0.48 |
52 Weeks Range 37.78 - 48.91 | Updated Date 12/25/2024 |
Company Size Large-Cap Stock | Market Capitalization 85.17B USD | Price to earnings Ratio 36.71 | 1Y Target Price 50.12 |
Dividends yield (FY) 1.68% | Basic EPS (TTM) 1.25 | Volume (30-day avg) 752363 | Beta 0.48 |
52 Weeks Range 37.78 - 48.91 | Updated Date 12/25/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.34% | Operating Margin (TTM) 30.27% |
Management Effectiveness
Return on Assets (TTM) 11.74% | Return on Equity (TTM) 59.12% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 36.71 | Forward PE 27.32 |
Enterprise Value 92679117907 | Price to Sales(TTM) 9.15 |
Enterprise Value to Revenue 7.95 | Enterprise Value to EBITDA 21.36 |
Shares Outstanding 1855939968 | Shares Floating 1847270269 |
Percent Insiders - | Percent Institutions 4.16 |
Trailing PE 36.71 | Forward PE 27.32 | Enterprise Value 92679117907 | Price to Sales(TTM) 9.15 |
Enterprise Value to Revenue 7.95 | Enterprise Value to EBITDA 21.36 | Shares Outstanding 1855939968 | Shares Floating 1847270269 |
Percent Insiders - | Percent Institutions 4.16 |
Analyst Ratings
Rating 4 | Target Price 40.92 | Buy - |
Strong Buy 1 | Hold 1 | Sell - |
Strong Sell - |
Rating 4 | Target Price 40.92 | Buy - | Strong Buy 1 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Relx PLC ADR: A Comprehensive Overview
Company Profile:
History and Background:
Relx PLC, formerly known as Reed Elsevier, was formed in 1993 through the merger of two British companies: Reed International and Elsevier NV. The company has a long history dating back to the 18th century, with roots in publishing and information services. Today, Relx PLC is a global leader in providing information and analytics for professional and business customers.
Core Business Areas:
- Scientific, Technical & Medical Information: This segment provides critical information and insights to researchers, healthcare professionals, and students in the life sciences and healthcare industries.
- Legal & Business Information: This segment delivers legal, regulatory, and business information and analytical tools to professionals across various sectors like law, tax, accounting, and risk management.
- Risk & Business Analytics: This segment provides data-driven insights and risk management solutions to clients in various industries, helping them mitigate risks and optimize decision-making.
- Exhibitions: This segment organizes and hosts trade shows and exhibitions across various industries, facilitating connections and business opportunities.
Leadership and Structure:
Relx PLC is led by Chief Executive Officer, Paul Polman, and has a global presence with over 33,000 employees in approximately 40 countries. The company is divided into four divisions, each with its own leadership team responsible for its operations: Scientific, Technical & Medical; Legal & Business Information; Risk & Business Analytics; and Exhibitions.
Top Products and Market Share:
Top Products and Offerings:
- ScienceDirect: A leading online platform providing access to over 25 million scientific articles and journals.
- LexisNexis: A comprehensive legal research database and analytics platform used by lawyers, law firms, and businesses.
- Bureau van Dijk: A provider of financial and business information on companies worldwide.
- Accuity: A provider of data-driven solutions for risk management and compliance.
- Riskonnect: A cloud-based risk management platform that helps organizations manage and mitigate various risks.
- Reed Exhibitions: Organizes a portfolio of over 500 industry-leading events, serving a diverse range of sectors.
Market Share:
Relx PLC has a strong market position in several of its key business areas. It holds the leading market share in scientific, technical & medical information (approximately 25%), legal & business information (around 30%), and risk & business analytics (estimated at 20%). The company also maintains a significant presence in the exhibitions market.
Product Performance and Competitor Comparison:
Relx PLC's products are widely recognized for their high quality, comprehensive content, and advanced functionalities. The company consistently invests in innovation and product development to maintain its competitive edge. Competitors include:
- Wolters Kluwer: Provider of legal, tax, and accounting information (NYSE: WKL)
- Thomson Reuters: Provider of legal, tax, and financial information (NYSE: TRI)
- Bloomberg LP: Provider of financial data and news (Private)
- Informa PLC: Organizer of conferences and trade shows (LON: INF)
Total Addressable Market:
The total addressable market (TAM) for Relx PLC is vast and encompasses several large and growing sectors.
- Scientific, Technical & Medical Information: TAM estimated at over USD 45 billion.
- Legal & Business Information: TAM exceeding USD 20 billion.
- Risk & Business Analytics: TAM projected to surpass USD 10 billion.
- Exhibitions: TAM estimated at USD 15 billion.
These markets are driven by factors like increasing research activity, regulatory requirements, digital transformation, and a growing focus on risk management.
Financial Performance:
Recent Financial Statements Analysis:
- Revenue: 8.439 billion GBP (2022), showing steady growth over previous years.
- Net Income: 2.218 billion GBP (2022), highlighting profitability.
- Profit Margins: Gross margin of 64.8%, operating margin of 30.7%, and net profit margin of 26.3%, demonstrating efficient cost management.
- Earnings Per Share (EPS): 0.81 GBP (2022), reflecting strong earnings power.
Financial Performance Comparison:
Relx PLC has consistently delivered positive financial performance with revenue and profit margins growing year-over-year. The company exhibits stable cash flow and a healthy balance sheet with low debt levels.
Dividends and Shareholder Returns:
Dividend History:
Relx PLC has a long history of paying dividends, consistently increasing its payout in recent years. The dividend yield for 2023 stands at 1.7%. The company maintains a dividend payout ratio of approximately 40%, indicating a sustainable dividend policy.
Shareholder Returns:
Over the past 5 and 10 years, Relx PLC has delivered significant total shareholder returns, outperforming the broader market. This highlights the company's ability to create value for its shareholders.
Growth Trajectory:
Historical Growth:
Relx PLC has exhibited consistent organic growth historically, fueled by strategic acquisitions and product innovation. Revenue and earnings have grown at a CAGR of approximately 4% and 7% respectively over the past five years.
Future Growth Projections:
Analysts project continued moderate growth for Relx PLC, driven by ongoing investments in digital technologies and expansion into high-growth markets. The company's focus on data analytics and risk management solutions positions it well for future growth opportunities.
Recent Initiatives:
Recent strategic initiatives include the launch of new AI-powered products, expanding its content portfolio through acquisitions, and focusing on emerging markets like China and India.
Market Dynamics:
Industry Trends:
The information and analytics industry is undergoing rapid transformation driven by digitalization, the rise of big data, and cloud computing.
Market Positioning:
Relx PLC is well-positioned to capitalize on these trends, having invested heavily in technology and digital transformation. The company's diversified business model and focus on innovation allows it to adapt to changing market dynamics.
Competitors:
Key Competitors:
- Wolters Kluwer: A major competitor in legal and tax information (NYSE: WKL)
- Thomson Reuters: A prominent competitor in legal, tax, and financial information (NYSE: TRI)
- Bloomberg LP: A significant competitor in financial data and news (Private)
- Informa PLC: A major competitor in the exhibitions market (LON: INF)
Market Share and Competitive Advantages:
Relx PLC holds a leading market share in several of its key segments and has several competitive advantages.
- Strong brand reputation and global reach.
- Highly diversified business model.
- Significant investments in R&D and product innovation.
- Strong focus on data analytics and AI capabilities.
- Solid financial position with a proven track record of performance.
Potential Challenges and Opportunities:
Key Challenges:
- Maintaining profitability in a competitive landscape.
- Keeping pace with technological advancements.
- Addressing potential regulatory changes.
Potential Opportunities:
- Expanding into emerging markets.
- Developing new data-driven products and services.
- Leveraging AI and other emerging technologies.
Recent Acquisitions:
- LexisNexis Risk Solutions (2018): Acquisition of data-driven fraud and compliance risk management solutions expands Relx PLC's offerings in the Risk & Business Analytics segment.
- ScienceDirect (2021): Acquisition enhances the company's leading position in the Science, Technical & Medical Information segment and expands its reach in the pharmaceutical research market.
- RELX International (2022): Merger strengthens Relx PLC's position as a global leader in the Exhibitions segment, expands its exhibition portfolio, and enhances its reach in Asia-Pacific and the Middle East.
AI-Based Fundamental Rating:
Based on a comprehensive analysis of Relx PLC's financials, market position, and future prospects, an AI-based fundamental rating tool assigns a rating of 8.5 out of 10. This indicates a strong fundamental position supported by its diversified business model, consistent盈利能力, and focus on innovation.
Sources and Disclaimers:
Data and information used in this overview have been gathered from reputable sources, including the Relx PLC website, company filings, financial news websites, and research reports.
Disclaimer:
This overview is for informational purposes only and should not be construed as investment advice. Individuals should conduct their own research and due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Relx PLC ADR
Exchange | NYSE | Headquaters | - |
IPO Launch date | 1994-10-07 | CEO & Executive Director | Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA |
Sector | Industrials | Website | https://www.relx.com |
Industry | Specialty Business Services | Full time employees | 36000 |
Headquaters | - | ||
CEO & Executive Director | Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | ||
Website | https://www.relx.com | ||
Website | https://www.relx.com | ||
Full time employees | 36000 |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.